Skip to main content
SpringerLink
Log in

Epidemiology of Adverse Drug Events in the Nursing Home Setting

  • Review Article
  • Epidemiology
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

There is widespread concern about the level of use, particularly the inappropriate use, of drugs among elderly residents of nursing homes. Medication consumption by these individuals is among the highest of any patient population; residents of nursing homes are prescribed an average of 5 to 8 regularly scheduled medications in addition to those drugs prescribed on an as needed (‘prn’) basis. Ideally, drug therapy should result in beneficial effects and improved quality of life for patients. However, the development of adverse drug events (ADEs) can compromise the expected benefits of pharmacotherapy for the individual nursing-home resident and may represent a public health problem of considerable magnitude.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gurwitz JH, Soumerai SB, Avorn A. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990; 38: 542–52

    PubMed  CAS  Google Scholar 

  2. Ray WA, Federspiel CF, Schaffner W. A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. Am J Public Health 1980; 70: 485–9

    Article  PubMed  CAS  Google Scholar 

  3. Svarstad BL, Mount JK. Nursing home resources and tranquilizer use among the institutionalized elderly. J Am Geriatr Soc 1991; 39: 869–75

    PubMed  CAS  Google Scholar 

  4. Beers M, Avorn J, Soumerai SB, et al. Psychoactive medication use of intermediate-care facility residents. JAMA 1988; 260: 3016–20

    Article  PubMed  CAS  Google Scholar 

  5. Burns BJ, Kamerow DB. Psychotropic drug prescriptions for nursing home residents. J Fam Pract 1988; 26: 155–60

    PubMed  CAS  Google Scholar 

  6. Avorn J, Dreyer P, Connelly K, et al. Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study. N Engl J Med 1989; 320: 227–32

    Article  PubMed  CAS  Google Scholar 

  7. Beardsley RS, Larson DB, Burns BJ, et al. Prescribing of psychotropics in elderly nursing home patients. J Am Geriatr Soc 1989; 37: 327–30

    PubMed  CAS  Google Scholar 

  8. Requirements for long-term care facilities. Federal Register 1991; 56 No. 187: 206–16

    Google Scholar 

  9. Garrard J, Makris L, Dunham T, et al. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. JAMA 1991; 265; 463–7

    Article  PubMed  CAS  Google Scholar 

  10. Beers MH, Ouslander JG, Rollinger I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825–32

    Article  PubMed  CAS  Google Scholar 

  11. Gurwitz JH. Suboptimal medication use in the elderly — the tip of the iceberg. JAMA 1994; 272: 316–7

    Article  PubMed  CAS  Google Scholar 

  12. Lederle FA, Applegate WB, Grimm RH. Reserpine and the medical marketplace. Arch Intern Med 1993; 153: 705–6

    Article  PubMed  CAS  Google Scholar 

  13. Gurwitz JH, Avorn J, Ross-Degan D, et al. Nonsteroidal antiinflammatory drug-associated azotemia in the very old. JAMA 1990; 264: 471–5

    Article  PubMed  CAS  Google Scholar 

  14. Rodriguez LAG, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 769–72

    Article  Google Scholar 

  15. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684–9

    PubMed  CAS  Google Scholar 

  16. Gurwitz JH, Sanchez-Cross MI, Eckler MA, et al. The epidemiology of adverse and unexpected events in the long-term care setting. J Am Geriatr Soc 1994; 42: 33–8

    PubMed  CAS  Google Scholar 

  17. Gerety MB, Cornell JE, Plichta DT, et al. Adverse events related to drugs and drug withdrawal in nursing home residents. J Am Geriatr Soc 1993; 41: 1326–32

    PubMed  CAS  Google Scholar 

  18. Nolan L, O’Malley K. Prescribing for the elderly — part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988; 36: 142–9

    PubMed  CAS  Google Scholar 

  19. Nolan L, O’Malley K. Prescribing for the elderly — part II: prescribing patterns: differences due to age. J Am Geriatr Soc 1988; 36: 245–54

    PubMed  CAS  Google Scholar 

  20. World Health Organization. International drug monitoring: the role of the hospital. Drug Intell Clin Pharm 1970; 4: 101

    Google Scholar 

  21. Classen DC, Pestotnik SL, Evans S, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847–51

    Article  PubMed  CAS  Google Scholar 

  22. Soon JA. Developing an adverse drug reaction program in nursing homes. Can J Hosp Pharm 1980; 33: 158–64

    PubMed  CAS  Google Scholar 

  23. Smith JW, Seidl LG, Cluff LE. Studies on the epidemiolgy of adverse drug reactions. Ann Intern Med 1966; 65: 629–40

    PubMed  CAS  Google Scholar 

  24. Hurwitz N. Predisposing factors in adverse reactions to drugs. BMJ 1969; 1: 536–9

    Article  PubMed  CAS  Google Scholar 

  25. Avorn J, Monane M, Everitt DE, et al. Clinical assessment of extrapyramidal signs in nursing home patients given antipsychotic medication. Arch Intern Med 1994; 154: 1113–7

    Article  PubMed  CAS  Google Scholar 

  26. Avorn J, Bohn R, Mogun H, et al. Nwuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study. Am J Med 1995; 99: 48–55

    Article  PubMed  CAS  Google Scholar 

  27. Rubeinstein LZ, Robbins AS, Schulman BL, et al. Falls and instability in the elderly. J Am Geriatr Soc 1991; 39: 591–605

    Google Scholar 

  28. Sobel KG, McCart GM. Drug use and accidental falls in an intermediate care facility. Drug Intell Clin Pharm 1983; 17: 539–42

    PubMed  CAS  Google Scholar 

  29. Granek E, Baker SP, Abbey H, et al. Medications and diagnosis in relation to falls in a long-term care facility. J Am Geriatr Soc 1987; 35: 503–11

    PubMed  CAS  Google Scholar 

  30. Lipsitz LA, Jonsson PV, Kelley MM, et al. Causes and correlates of recurrent falls in ambulatory frail elderly. J Gerontol 1991; 46: M114–22

    PubMed  CAS  Google Scholar 

  31. Kerman M, Mulvihill M. The role of medication in falls among the elderly in a long-term care facility. Mt Sinai J Med 1990; 57: 343–7

    PubMed  CAS  Google Scholar 

  32. Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. Am J Med 1986; 80: 429–34

    Article  PubMed  CAS  Google Scholar 

  33. Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363–9

    Article  PubMed  CAS  Google Scholar 

  34. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262: 3303–7

    Article  PubMed  CAS  Google Scholar 

  35. Goldstein SE, Birnbom F, Lancee WJ, et al. Comparison of oxazepam, flurazepam and chloral hydrate as hypnotic sedatives in geriatric patients. J Am Geriatr Soc 1978; 26: 366–71

    PubMed  CAS  Google Scholar 

  36. Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (part I). Clin Pharmacokinet 1991; 21: 165–77

    Article  PubMed  CAS  Google Scholar 

  37. Greenblatt DJ, Allen DA. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol 1978; 5: 407–13

    Article  PubMed  CAS  Google Scholar 

  38. Greenblatt DJ, Shader Rl, Harmatz JS. Implications of altered drug disposition in the elderly: studies of benzodiazepines. J Clin Pharmacol 1989; 29: 866–72

    PubMed  CAS  Google Scholar 

  39. Stevens A, Mulrow C. Drugs affecting postural stability and other risk factors in the hip fracture epidemic-case-control study. Community Med 1989; 11: 27–34

    PubMed  CAS  Google Scholar 

  40. Larson EB, Kukull WA, Buchner D, et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med J 1987; 107: 169–73

    CAS  Google Scholar 

  41. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767–73

    Article  PubMed  CAS  Google Scholar 

  42. Tinetti ME, Baker DI, Garrett PA, et al. Yale FICS1T: risk factor abatement strategy for fall prevention. J Am Geriatr Soc 1993; 41: 315–20

    PubMed  CAS  Google Scholar 

  43. Feinberg M. The problems of anticholinergic adverse effects in older adults. Drugs Aging 1993; 3: 335–48

    Article  PubMed  CAS  Google Scholar 

  44. Blazer II DG, Ferderspiel CP, Ray WA, et al. The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. J Gerontol 1983; 38: 31–5

    PubMed  Google Scholar 

  45. Monane M, Avorn J, Beers MH, et al. Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med 1993; 153: 633–8

    Article  PubMed  CAS  Google Scholar 

  46. Harari D, Gurwitz JH, Minaker KL. Constipation in the elderly. J Am Geriatr Soc 1993; 41: 1130–40

    PubMed  CAS  Google Scholar 

  47. Gurwitz JH, Avorn J, Ross-Degan D, et al. Nonsteroidal antiinflammatory drug-associated azotemia in the very old. JAMA 1990; 264: 471–5

    Article  PubMed  CAS  Google Scholar 

  48. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115: 787–96

    PubMed  CAS  Google Scholar 

  49. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359–63

    PubMed  CAS  Google Scholar 

  50. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257–63

    PubMed  CAS  Google Scholar 

  51. Gurwitz JH, Avorn J, Ross-Degan D, et al. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA 1990; 264: 471–5

    Article  PubMed  CAS  Google Scholar 

  52. Gurwitz JH, Avorn J, Bohn RL, et al. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA 1994; 272: 781–6

    Article  PubMed  CAS  Google Scholar 

  53. Ray WA, Griffin MR, Avorn J. Evaluating drugs after their approval for clinical use. N Engl J Med 1993; 329: 2029–32

    Article  PubMed  CAS  Google Scholar 

  54. Bradley JD, Brandt KD, Kalasinki LA, et al. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325: 87–91

    Article  PubMed  CAS  Google Scholar 

  55. Kovar PA, Allegrande JP, MacKenzie CR, et al. Supervised fitness walking in patients with osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 1992; 116: 529–34

    PubMed  CAS  Google Scholar 

  56. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992; 327: 168–73

    Article  PubMed  CAS  Google Scholar 

  57. Ray WA, Taylor JA, Meador KG, et al. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med 1993; 153: 713–21

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Program for the Analysis of Clinical Strategies, Gerontology Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA

    Johanne Monette,  Jerry H. Gurwitz & Jerry Avorn

  2. Brockton/West Roxbury Veterans Affairs Medical Center, West Roxbury, Massachusetts, USA

    Johanne Monette,  Jerry H. Gurwitz & Jerry Avorn

Authors
  1. Johanne Monette
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerry H. Gurwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jerry Avorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Monette, J., Gurwitz, J.H. & Avorn, J. Epidemiology of Adverse Drug Events in the Nursing Home Setting. Drugs & Aging 7, 203–211 (1995). https://doi.org/10.2165/00002512-199507030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199507030-00005

Keywords

Search

Navigation